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AbstrACt
background White cell count (WCC) is a clinical marker 
of inflammation. Data are limited regarding the association 
of total and differential WCC with risk of mortality, and its 
role related with smoking and body mass index (BMI).
Methods A total of 14 433 participants (4150 men; 
10 283 women; average age 47.3±11.8 years) from the 
Dutch European Prospective Investigation into Cancer 
and Nutrition- Netherlands cohort were included. The 
associations between prediagnostic total WCC and its 
subtypes and risk of all- cause, cancer and cardiovascular 
disease (CVD) mortality were assessed. The role of WCC 
related with smoking and BMI on mortality was further 
explored. Multivariate Cox regression models were 
performed to estimate the HR and 95% CI.
results After an average follow- up of 15.8 years, a 
total of 936 death cases were identified (466 cancer; 
179 CVD; 291 other causes). Statistically significant 
graded associations between total WCC, and counts of 
lymphocytes, monocytes, neutrophils and eosinophils and 
risk of total mortality were observed. These associations 
were more apparent in current smokers. Strong 
associations for all- cause mortality or cancer mortality 
were observed in subjects with BMI ≥25 kg/m2, ever 
smoking and elevated WCC (HR 3.92, 95% CI 2.76 to 
5.57; HR 3.93, 95% CI 2.30 to 6.72). WCC partly mediated 
the associations between smoking or BMI and all- cause 
mortality.
Conclusions Prediagnostic WCC and its subtypes are 
associated with all- cause, cancer and CVD mortality risk. 
It may play a partially mediate role on the association 
between smoking or obesity and mortality.
IntroduCtIon
White cell counts (WCC) include several 
cell types (lymphocytes, monocytes, neutro-
phils, eosinophils and basophils) and are 
widely considered as sensitive biomarkers of 
systemic inflammation. Although quite a few 
studies have found WCC is a good predictor 
of survival in patients with certain clinical 
diagnoses, studies on the association of this 
inexpensive and ubiquitous test with mortality 
in the healthy population are insufficient and 
inconsistent. A number of studies have asso-
ciated WCC with cancer mortality, cardiovas-
cular diseases (CVDs) mortality and all- cause 
mortality especially in elderly population or 
female population with limited sample size,1–6 
leaving inadequate evidence from the general 
population.
A few studies have shown that WCC or 
subtype is an independent predictor of 
mortality after controlling for potential 
confounding, for example, smoking.1 5 7–12 
This conclusion, however, might conflict with 
the fact that the WCC is influenced by many 
factors, such as infection, inflammation, 
smoking and obesity. Cigarette smoking is a 
well- recognised cause of elevated WCC.13 14 
Smokers have higher WCC than non- smokers, 
and the extent of the increase rises with the 
number of cigarettes smoked.15 Obesity, an 
important risk factor for the development 
of CVD such as hypertension, diabetes and 
dyslipidaemia, is also associated with substan-
tial increases in WCC.16 17 Therefore, the asso-
ciation of WCC or subtype on mortality might 
be mediated by smoking or obesity, however, a 
few studies have investigated whether WCC or 
subtype played a mediate role on the pathway 
strengths and limitations of this study
 ► It is large prospective cohort study with a long 
follow- up period.
 ► Blood samples were collected at baseline and mea-
sured with standardised approaches.
 ► Other information, including smoking, physical ac-
tivity, educational level, alcohol consumption and 
anthropometric variables, was collected.
 ► Only one measurement of white cell count was 
performed.
 ► Multiple comparisons were used in the analyses, 
which might produce smaller p values by chance 
and exaggerate type I error.
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from smoking to mortality, or from obesity to mortality, 
or whether the three factors play a joint role on mortality.
Evidence of WCC subtype as a predictor of mortality 
in healthy populations is limited and largely inconsistent. 
Higher neutrophils2 3 or lower lymphocytes3 18 19 were 
associated with increased mortality, but no associations 
were found in other subtype in the same study.3 Several 
studies have shown that monocyte counts have been inde-
pendently associated with all- cause,2 20 CVD2 21 or cancer- 
related mortality,2 20 while other studies have reported no 
association.3 22 A U- shaped association of eosinophil count 
with all- cause mortality was reported in a Danish study.23 
Smoking or obesity has been associated with differential 
WCC subtype,24 25 while whether this impacts mortality 
differently is unknown. Due to the differential function 
of WCC subtype in the immune system, more studies on 
mortality of general populations are warranted.
In order to further clarify the role of WCC and its 
subtype on the risk of all- cause, CVD and cancer mortality, 
we initiated an analysis using data from the European 
Prospective Investigation into Cancer and Nutrition- 
Netherlands (EPIC- NL), a prospective cohort recruited 
from the generally healthy population in the Nether-
lands.26 Specifically, we gauged the relation of WCC and 
its subtype with smoking and obesity, and further exam-
ined the joint effect of those factors on mortality.
MAterIAls And Methods
study population
This prospective cohort study combines the two Dutch 
cohorts of the EPIC, the EPIC- Medical Ethical Committee 
of TNO Nutrition and Food Research (MORGEN) 
and EPIC- Prospect,27 which were set up simultane-
ously between 1993 and 1997. The EPIC- Prospect study 
includes 17 357 women aged 49–70 years living in Utrecht 
and its vicinity who participated in the nationwide Dutch 
breast cancer screening programme. The EPIC- MORGEN 
cohort consists of 22 654 men and women aged 21–64 
years selected from random samples of the Dutch popu-
lation in three different towns (Doetinchem, Amsterdam, 
Maastricht). At baseline, all participants filled out a 
general questionnaire and a validated food frequency 
questionnaire and underwent a physical examination. All 
participants provided written informed consent before 
study inclusion.
Beginning June 1995, after 19 214 subjects had been 
enrolled, a blood sample was drawn of all subsequent 
subjects for measurement of blood cell count at entry into 
the cohort. For the remaining inclusion period, blood 
cell counts were not available in some cohort partici-
pants. Moreover, valid smoking data were missing for 156 
subjects. With further removal of 253 participants who 
never had followed up, we initially had 15 973 participants 
included in this study. Participants with a baseline history 
of cancer (n=555), stroke and heart diseases (n=397), 
diabetes (n=259) and comorbidity of above two or three 
diseases (n=86) were excluded. Moreover, participants 
with missing values (n=243) were further excluded. A 
total of 14 433 (4150 men and 10 283 women) partici-
pants were included in the present study.
Patient and public involvement
We appreciated all patients who participated in the 
study and contributed their personal information to the 
research. All patients and the public, however, were not 
involved in the design or planning of the study.
Blood collection
The blood sample for measurement of the complete blood 
cell count was drawn in an ethylenediaminetetraacetic 
acid (EDTA) Monovette at entry into the cohort. The 
storage process as well as the analysis of blood samples 
was described previously.13 Total WCC and subtypes, 
including absolute counts of lymphocytes, monocytes, 
neutrophils and eosinophils, were measured using stan-
dard automated clinical methodologies.
Covariates
Information on sex (male, female), age (years) at 
study entry, educational level, smoking habit, alcohol 
consumption and physical activity was obtained by ques-
tionnaire. Educational level was grouped into four cate-
gories: primary school, technical/professional education, 
secondary school and longer education (including univer-
sity). Smoking was defined as never, former (quit smoking 
>20 years ago, quit 10–20 years ago, quit ≤10 years ago) 
and current smoker (1–15, 16–25, >16 cigarettes/day), 
therefore coding included seven categories. Smokers 
were also asked if they were pipe or cigar smoker. Alcohol 
consumption was considered as a continuous variable 
(gram of ethanol/day). Physical activity was categorised 
into four levels: inactive, moderately inactive, moderately 
active or active according to the validated Cambridge 
Physical Activity Index.28 Body mass index (BMI, kg/m2) 
was calculated dividing body weight (kg) by the square 
of the body height (m2), and waist circumferences were 
measured by centimetres.
Outcome assessment
The outcomes of interest were all- cause, cancer and 
CVD mortality. EPIC- NL participants were followed for 
vital status and date of death by regular linkage with the 
municipal registries. Subsequently, causes of death for 
deceased persons were obtained through linkage with 
Statistics Netherlands. Follow- up was complete through 
31 December 2012.
Statistical analyses
Descriptive statistics of baseline characteristics are 
presented for all participants by categories of WCC. Cox 
proportional hazards regression models were used to 
estimate the HR and 95% CI of the associations between 
WCC, its subtypes (lymphocytes, monocytes, neutro-
phils and eosinophils) and all- cause, cancer and CVD 
mortality. Distributions of WCC are shown by tertiles 
(T1=WCC ≤5.7×10
9/L; T2=WCC >5.7×10
9/L -<7.2×109/L; 
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T3=WCC ≥7.2×10
9/L). Categories based on clinical stan-
dard ranges were also considered and analysed. Due to 
limited number in certain categories using clinical stan-
dard range, we only reported results based on tertiles. The 
follow- up of all participants in the cohort started since the 
date of study entry, and censored at the date of death, 
lost to follow- up or 31 December 2012, whichever came 
first. We used attained age as the time scale in the Cox 
regression model. Proportional hazard assumption was 
tested based on Schoenfeld residuals. In some models, 
sex did not meet the assumption. We then set it as a strata 
variable. Cox regression models were stratified by age (set 
as an integer) and sex and were adjusted for potential 
confounders: educational level, smoking habit, alcohol 
consumption, physical activity, BMI and waist circumfer-
ence. Linear trend across tertiles was assessed by model-
ling the median of each tertile as a continuous variable. 
To test for effect modification of WCC and subtypes on 
mortality risk by BMI, waist circumference or smoking, 
we used a likelihood ratio test to compare the model with 
and without interaction terms.
In order to measure the joint effect of BMI, smoking 
and WCC, a new variable was created by combining 
BMI (<25 and ≥25 kg/m2), WCCcategories (≤10, 
>10×109 cells/L, based on clinical standard range) 
and smoking status (no smoking or ever smoking). 
The combined category of normal WCC range (≥4 to 
≤10×109 cells/L) with BMI <25 kg/m2 and never smoking 
was chosen as reference. Analyses of joint effects were 
controlled for age and sex in the basic model (model 1), 
or age, sex, alcohol consumption, physical activity and 
educational level in the second model.
In order to assess if counts of WCC are a mediating 
factor between smoking, or obesity and risk of mortality, 
we performed a mediation analysis based on counterfac-
tual mediation modelling.29–31 Proportion mediated was 
calculated based on indirect effects divided by total effects. 
This method, unfortunately, has not been well developed 
in application to time- to- event data. Therefore, we also 
calculated mediation using the traditional ‘change- in- 
estimate’ method.32 33 We calculated the quantification 
of the percentage reduction in estimate (smoking) after 
controlling for the potential mediating factor (WCC).
Two- sided p<0.05 were considered to be statistically 
significant. All statistical analyses were conducted using 
the statistical software package STATA V.12.0 (StataCorp).
results
baseline characteristics
A total of 14 433 participants were included in the analysis 
with a mean follow- up of 15.8±2.4 years. There were 936 
total deaths over 228 304 person- years of follow- up. The 
crude cumulative mortality rate was 4.1 per 1000 person- 
years. Among total deaths, 466 were due to cancer, 179 
due to CVDs and 291 due to other causes.
Baseline characteristics of the participants by tertile 
of WCC are reported in table 1. Proportions of men 
and women were similar across tertiles of WCC. Partic-
ipants were younger, more obese, less educated, less 
active physical activity and more current smokers in 
the higher tertiles of WCC, while alcohol consumption 
was similar across the tertiles of WCC. Analysis of WCC 
subtypes revealed significantly higher lymphocyte, mono-
cyte, neutrophil and eosinophils levels among all- cause 
and disease- specific mortality cases compared with all 
participants.
Association between total WCC, its subtypes and mortality
The association between WCC, its subtypes and all- cause, 
cancer and CVD mortality is shown in table 2. After multi-
variate adjustment, a statistically significant association 
between total WCC (HRT3vsT1: 1.38, 95% CI 1.17 to 1.64, 
p<0.0001), lymphocytes (HRT3vs T1: 1.21, 95% CI 1.02 to 
1.43, p=0.025), monocytes (HRT3vs T1: 1.22, 95% CI 1.04 to 
1.43, p=0.016), neutrophils (HRT3vs T1: 1.29, 95% CI 1.09 
to 1.52, p=0.002) and eosinophils (HRT3vs T1: 1.25, 95% CI 
1.05 to 1.49, p=0.017) and all- cause mortality risk was 
observed. A significant association was observed between 
total WCC and CVD mortality (HRT3vs T1: 1.53, 95% CI 
1.03 to 2.26, p=0.031), but not cancer mortality (HRT3vs 
T1: 1.13, 95% CI 0.89 to 1.44, p=0.282). The associations 
for subtypes of WCC were not statistically significant for 
cancer and CVD mortality. No significant association was 
found for neutrophil- to- Lymphocyte ratio (NLR) and 
mortality (table 2).
total WCC, its subtype and mortality by smoking status
Interactions between WCC (or its subtype) and smoking 
status were consistently significant, while no interaction 
was found for WCC and BMI, or waist circumference 
except eosinophils and waist circumference. We further 
stratified the analyses by smoking status (table 3). The 
results showed that total WCC and all WCC subtypes were 
statistically significantly associated with total mortality in 
current smokers, while the associations were attenuated 
or disappeared in never and former smokers. Total WCC 
and lymphocytes were significantly associated with cancer 
mortality risk in current smokers, whereas only total WCC 
was significantly associated with CVD mortality in current 
smokers (data not shown). In former smokers, the NLR 
was positively associated with CVD mortality, but mono-
cytes count was negatively associated with CVD mortality.
Joint effects of bMI, smoking, WCC and mortality
A high WCC BMI in addition to being a current or former 
smoker was strongly and significantly associated with all- 
cause and cancer mortality risk, regardless of BMI status 
(table 4). Subjects with BMI <25 kg/m2 who were also 
current or former smokers with normal WCC showed 
an increased risk for all- cause and cancer mortality (HR 
1.55, 95% CI 1.21 to 1.99; HR 2.00, 95% CI 1.37 to 2.92, 
respectively). This association was not strengthened when 
BMI was elevated (HR 1.42, 95% CI 1.11 to 1.80; HR 
1.80, 95% CI 1.25 to 2.60, respectively), but apparently 
enhanced when WCC increases irrespective of level of 
4 Abete I, et al. BMJ Open 2019;9:e030949. doi:10.1136/bmjopen-2019-030949
Open access 
Table 1 Basic characteristics of cohort participants by tertiles of white cell count (WCC)
WCC
All participants T1 (≤5.7) T2 (5.8–7.1) T3 (≥7.2)
N 14 433 5146 4514 4773
  Men (%) 4150 28.75 1502 29.19 1316 29.15 1332 27.91
  Women (%) 10 283 71.25 3644 70.81 3198 70.85 3441 72.09
Age at recruitment (mean±SD) 47.3±11.8 48.1±12.0 47.1±12.0 46.7±11.3
BMI, n (%)
  <25 kg/m2 7022 48.65 2702 52.51 2113 46.81 2207 46.24
  ≥25 to <30 kg/m2 5539 38.38 1925 37.41 1784 39.52 1830 38.34
  ≥30 kg/m2 1872 12.97 519 10.09 617 13.67 736 15.42
Waist size (cm) 85.1 ±11.5 83.6 ±10.7 85.3 ±11.5 86.3 ±12.1
Educational level, n (%)
  Primary school 1794 12.43 546 10.61 571 12.65 677 14.18
  Technical/professional 5082 35.21 1760 34.20 1540 34.12 1782 37.34
  Secondary school 4078 28.25 1439 27.96 1279 28.33 1360 28.49
  Longer education (inclu. university) 3479 24.10 1401 27.23 1124 24.90 954 19.99
Physical activity, n (%)
Inactive 1015 7.03 249 4.84 306 6.78 460 9.64
  Moderately inactive 3510 24.32 1206 23.44 1065 23.59 1239 25.96
  Moderately active 3850 26.67 1420 27.59 1209 26.78 1221 25.58
  Active 6058 41.97 2271 44.13 1934 42.84 1853 38.82
Smoking habits, n (%)
  Never 5479 37.96 2462 47.84 1774 39.30 1243 26.04
  Former 4455 30.87 1889 36.71 1499 33.21 1067 22.35
  Current 4499 31.17 795 15.45 1241 27.49 2463 51.60
Alcohol intake, gram/day (median, IQR) 5.9 ±16.2 6.1 ±15.1 5.9 ±16.2 5.8 ±18.1
BMI, body mass index.
BMI (in those with BMI <25 hours 3.15, 95% CI 2.07 to 
4.81; HR 2.71, 95% CI 1.37 to 5.38 and in those with BMI 
≥25 HR 3.92, 95% CI 2.76 to 5.57; HR 3.93, 95% CI 2.30 
to 6.72, respectively).
Mediation analysis
Based on the potential causality pathway and previous 
evidence between smoking and WCC or obesity and 
WCC, we tested mediation of WCC between smoking 
(ever smoker vs never smoker) and total mortality, and 
between overweight (BMI >25 vs BMI ≤25 kg/m2) and 
total mortality, when smoking was treated as a primary 
exposure in the model. Using the counterfactual media-
tion modelling, we calculated the total effect, direct effect 
and indirect effect based on Cox regression model and 
linear regression model. The proportion mediated was 
32.7% (95% CI 30.1% to 41.1%) for smoking, and 6.4% 
(95% CI 5.3% to 5.9%) for BMI. Using the ‘change- in- 
estimate’ method, the proportion mediated was 27.9% 
(95% CI 19.1% to 49.4%) for smoking and 9.6% (95% CI 
5.5% to 38.3%) for BMI.
dIsCussIon
In this longitudinal study, we found that higher counts of 
total WCC and its subtypes are positively associated with a 
significantly higher risk of all- cause mortality. Highest risk 
of all- cause mortality was observed in ever smokers with 
elevated total WCC and higher BMI. WCC may be one of 
the mediating factors in the association between smoking 
or BMI and all- cause mortality.
Several previous studies have reported that WCC 
was associated with mortality even after adjusting for 
smoking.1 5 7–12 This is not fully consistent with our anal-
ysis in healthy population. In our study, the associa-
tions between total WCC and mortality were attenuated 
when smoking was incorporated into the model. In the 
analysis stratified by smoking status, all cause, CVD and 
cancer mortality were especially stronger in current 
smokers. Current cigarette smoking has been associated 
with increased WCC in many studies.15 34 Our data show 
that current smoking is also strongly related to WCC. 
The existence of low- grade inflammation in smokers 
may trigger the increase of WCC that fights against the 
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inflammation and damage caused by smoking.13 Interest-
ingly, several studies have demonstrated that current ciga-
rette smoking is a reversible cause of elevated WCC and 
quitting of smoking may lead to recovery of WCC.34 35 The 
non- significant results in former smokers in our study 
may further verify this point. Moreover, obesity has been 
defined as a state of chronic low- grade inflammation in 
which leucocytes might be involved.36 Quite a few studies 
have observed increased WCC among subjects with over-
weight or obesity7 22 37 38 suggesting that leucocytes are 
involved in the development of obesity- related comorbid-
ities. Stratified analysis by smoking status and joint effect 
analysis by smoking and BMI status showed apparent 
evidence for effect modification by smoking and BMI. 
The further mediation analyses indicated that WCC or its 
subtype may play in part a mediating role from smoking 
to mortality, or from obesity to mortality. In fact, the 
strongest associations between an increased total WCC 
and all- cause and cancer mortality were observed in ever 
smoking participants with BMI ≥25 kg/m2.
Few studies have investigated the risk associated with 
different WCC subtypes in healthy subjects. Our study 
showed that subtype of WCC was significantly associated 
with all- cause mortality after adjustment for smoking 
(status, intensity and duration), while the associations 
with cancer and CVD mortality were attenuated and 
became non- significant. Most previous studies that have 
evaluated WCC subtype with risk of mortality have been 
conducted in CVD subjects or patients with cancer, and 
few in general populations. Among healthy participants 
at baseline, an Asian cohort study (245 died in 8447 
study subjects) showed an inverse association between 
lymphocyte count and all- cause and cancer mortality, 
while neutrophil and monocyte counts were positively 
associated with CVD mortality.39 The Women’s Health 
and Aging Study (175 died in 624 community- dwelling 
women age 65–101) demonstrated that high total WCC, 
high neutrophil counts and low lymphocyte counts 
were associated with all- cause mortality3 while among 
elderly subjects, monocyte counts were associated with 
an increased risk of cardiovascular and cancer- related 
mortality.2 In a recent study from the UK (10 364 died in 
478 259 study participants), neutrophil counts were asso-
ciated with total mortality and CVD mortality, especially 
consistently associated with fatal and non- fatal CVD in 
men.
It is important to evaluate WCC subtypes for several 
reasons. First, they differ in their inflammation and 
immune functions. In addition, the different associations 
observed between the WCC subtypes and the outcomes 
considered (all- cause, cancer and CVD mortality) 
confirm their differential roles in the organism. Inflam-
mation plays an essential part in initiating tumourigenesis 
by damaging specific tissues, and neutrophils, monocytes 
and eosinophils are crucial components of this process.40 
However, in the present study, a stronger association was 
shown between total WCC and all- cause, cancer and CVD 
mortality compared with the subtypes. In contrast to our 
8 Abete I, et al. BMJ Open 2019;9:e030949. doi:10.1136/bmjopen-2019-030949
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findings, several studies have shown high neutrophil 
and low lymphocyte counts (the increased NLR) associ-
ated with mortality in general population. However, the 
NLR displayed no association with mortality in our study, 
while a significantly increased association was observed 
in persons who died of CVD before 70 years (data not 
showed). More interestingly, when we analysed the asso-
ciation of the NLR with total mortality by 1, 5, 6 and 10 
years follow- up, respectively (data not shown), we found 
the NLR is significantly associated with total mortality 
in short period of follow- up until 5 years but not in 6 
years or 10 years. It has been reported that the NLR is 
sensitive to the suppressive action of particularly acti-
vated myeloid cells. It may reflect the phenotypic action 
of a disease process and thus be less evident in a long 
prospective setting. Some studies have shown that the 
NLR was a good predictor of mortality41 42 in patients 
with CVDs or cerebrovascular disease, while our study 
participants were from the general population in which 
the role of NLR might be different. The NLR can reflect 
the balance between the activation of the inflammation 
pathway and the anti- inflammation immune function, 
and is a good biomarker for acute inflammation. There-
fore, the NLR can be a good predictor for patients with 
acutely clinical symptoms but not for mortality in general 
population.
A number of limitations of these analyses must 
be considered. Only one measurement of WCC was 
performed. Multiple comparisons were used in the anal-
yses, which might produce smaller p values by chance and 
exaggerate type I error. Some death cases (n=62) could 
not be classified because (1) the participant did not 
consent for linkage with causes of death database (n=18); 
(2) an error occurred in the linkage procedure (n=42) 
and (3) for unknown reasons (n=2). Even after adjust-
ment for the known risk factors, residual confounding 
may occur because of measurement error or unmeasured 
or unknown risk factors.
The present study has several strengths that should 
be emphasised as well. EPIC- NL is a large prospective 
cohort study that included both men and women from 
the general population, with a broad age range and a 
long follow- up period. Blood samples were collected at 
baseline and measured with standardised approaches. 
Information, including smoking, physical activity, educa-
tional level, and alcohol consumption, was collected 
using a structured questionnaire. Anthropometric vari-
ables were measured using standardised procedures. The 
cause of death of deceased participants was obtained 
through linkage with the municipal registry and Statistics 
Netherlands.
In summary, WCC and its subtypes are associated with 
an increased risk of all- cause mortality, and total WCC 
is associated with cancer and CVD mortality. WCC may 
play a partially mediate role on the pathway between 
smoking and mortality risk, and between obesity and 
mortality, when smoking was treated as a primary 
exposure.
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